ENLV - Enlivex Therapeutics Ltd.
1.02
-0.020 -1.961%
Share volume: 39,279
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.04
-0.02
-0.02%
Summary score
29%
Profitability
25%
Dept financing
5%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.33%
Return on assets
-17.54%
Return on sales
0%
Return on invested capital
121.52%
Total debt ratio
19.16%
Debt ratio change over timeo
0%
Current Ratio
5.87%
Quick Ratio
0%
Cash Position Ratio
3.94%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.76%
Return on assets
-6.09%
Return on sales
0%
Return on invested capital
79.67%
Total debt ratio
14.7%
Debt ratio change over timeo
0%
Current Ratio
7.04%
Quick Ratio
0%
Cash Position Ratio
2%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.46%
Return on assets
-5.87%
Return on sales
0%
Return on invested capital
81.48%
Total debt ratio
14.6%
Debt ratio change over time
0%
Current Ratio
7.23%
Quick Ratio
0%
Cash Position Ratio
1.44%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ENLV | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -22.33% | 18.71% | 4.67% | 19.62% |
| Return on assets | -17.54% | 3.4% | 3.32% | 11.24% |
| Return on sales | 0% | 24.27% | 25.81% | 41.89% |
| Return on invested capital | 121.52% | 5.38% | 4.17% | -280.52% |
| Profitability | 25% | 47% | 30% | 75% |
| Total debt ratio | 19.16% | 78.91% | 58.54% | 54.01% |
| Debt ratio change over time | 0% | 0% | 10.69% | 0% |
| Dept financing | 6% | 25% | 44% | 17% |
| Current Ratio | 7.04% | 1.21% | 1.33% | 1.08% |
| Quick Ratio | 0% | 0.94% | 1.07% | 0.79% |
| Cash Position Ratio | 2% | 0.21% | 0.6% | 0.32% |
| Liquididy | 50% | 28% | 35% | 23% |
| Short-term ratios | ENLV | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -8.76% | 41.05% | 6.87% | 16.13% |
| Return on assets | -6.09% | 3.67% | 3.13% | 8.75% |
| Return on sales | 0% | 26.16% | 24.75% | 38.84% |
| Return on invested capital | 79.67% | 9.43% | 5.58% | -6.74% |
| Profitability | 25% | 55% | 31% | 60% |
| Total debt ratio | 14.7% | 91.28% | 61.3% | 55.02% |
| Debt ratio change over time | 0% | 0% | 13.89% | 0% |
| Dept financing | 4% | 25% | 42% | 15% |
| Current Ratio | 7.04% | 1.21% | 1.33% | 1.08% |
| Quick Ratio | 0% | 0.94% | 1.07% | 0.79% |
| Cash Position Ratio | 2% | 0.21% | 0.6% | 0.32% |
| Liquididy | 50% | 29% | 37% | 26% |
